BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Demirbilek H, Cayir A, Flanagan SE, Yıldırım R, Kor Y, Gurbuz F, Haliloğlu B, Yıldız M, Baran RT, Akbas ED, Demiral M, Ünal E, Arslan G, Vuralli D, Buyukyilmaz G, Al-Khawaga S, Saeed A, Al Maadheed M, Khalifa A, Onal H, Yuksel B, Ozbek MN, Bereket A, Hattersley AT, Hussain K, De Franco E. Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations. J Clin Endocrinol Metab 2020;105:dgaa613. [PMID: 32893856 DOI: 10.1210/clinem/dgaa613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Miguel-Escalada I, Maestro MÁ, Balboa D, Elek A, Bernal A, Bernardo E, Grau V, García-Hurtado J, Sebé-Pedrós A, Ferrer J. Pancreas agenesis mutations disrupt a lead enhancer controlling a developmental enhancer cluster. Dev Cell 2022;57:1922-1936.e9. [PMID: 35998583 DOI: 10.1016/j.devcel.2022.07.014] [Reference Citation Analysis]
2 Bordeira-carriço R, Teixeira J, Duque M, Galhardo M, Ribeiro D, Acemel RD, Firbas PN, Tena JJ, Eufrásio A, Marques J, Ferreira FJ, Freitas T, Carneiro F, Goméz-skarmeta JL, Bessa J. Multidimensional chromatin profiling of zebrafish pancreas to uncover and investigate disease-relevant enhancers. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-29551-7] [Reference Citation Analysis]
3 Hammoud B, Greeley SAW. Growth and development in monogenic forms of neonatal diabetes. Curr Opin Endocrinol Diabetes Obes 2022;29:65-77. [PMID: 34864759 DOI: 10.1097/MED.0000000000000699] [Reference Citation Analysis]
4 Barbetti F, Rapini N, Schiaffini R, Bizzarri C, Cianfarani S. The application of precision medicine in monogenic diabetes. Expert Review of Endocrinology & Metabolism. [DOI: 10.1080/17446651.2022.2035216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Moravej H, Mirrashidi FS, Haghighi A, Amirhakimi A, Ilkhanipoor H. Neonatal Diabetes Due to a Mutation in the Distal PTF1A Enhancer: A Case Report and Literature Review. Iran J Pediatr 2021;32. [DOI: 10.5812/ijp.114059] [Reference Citation Analysis]
6 De Franco E. Neonatal diabetes caused by disrupted pancreatic and β-cell development. Diabet Med 2021;38:e14728. [PMID: 34665882 DOI: 10.1111/dme.14728] [Reference Citation Analysis]
7 Duque M, Amorim JP, Bessa J. Ptf1a function and transcriptional cis-regulation, a cornerstone in vertebrate pancreas development. FEBS J 2021. [PMID: 34125483 DOI: 10.1111/febs.16075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sanchez Caballero L, Gorgogietas V, Arroyo MN, Igoillo-Esteve M. Molecular mechanisms of β-cell dysfunction and death in monogenic forms of diabetes. Int Rev Cell Mol Biol 2021;359:139-256. [PMID: 33832649 DOI: 10.1016/bs.ircmb.2021.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]